Operating identity
The official story names Dane Fredericksen, PharmD as founder and lists 6351 Corte Del Abeto, Suite 111, Carlsbad, California. Board materials identify Forever Young Pharmacy Inc. dba Forever Young Pharmacy.
Pharmacy COA issuer · Reviewed 2026-09-03
Forever Young Pharmacy · United States
Legitimacy review
Forever Young has meaningful licensed-pharmacy identity evidence, but its in-house testing must be reviewed as pharmacy quality control. No independent-lab accreditation was found, and its own correction notice documents a past copied-control reporting error and corrective action.
The official story names Dane Fredericksen, PharmD as founder and lists 6351 Corte Del Abeto, Suite 111, Carlsbad, California. Board materials identify Forever Young Pharmacy Inc. dba Forever Young Pharmacy.
Named founder, regulated pharmacy identity, fixed facility, issued reports, and a specific public corrective-action notice.
California pharmacy licensure is not ISO/IEC 17025 laboratory accreditation. No independent analytical-lab certificate and scope was found.
The pharmacy publishes internally signed COAs and product-quality controls. Its own notice describes a copied control result, correction, and process changes.
The self-published correction is useful quality-system evidence because it acknowledges a specific reporting error; it does not independently validate the broader testing program.
The COAs are pharmacy-run, no independent-lab accreditation is confirmed, and analyst credentials should be described precisely. A pharmacy license establishes the pharmacy identity and status, not competence or independence for every analytical method.
COA verification
Submit the identifying certificate fields to the pharmacy quality-control team for a manual response.
Result handling
Verify only when the official issuer record exactly matches the certificate identity.
An explicit official no-record response is unresolved evidence, not proof that the certificate is invalid.
Quarantine the record when the identifier resolves to materially different issuer metadata; do not promote it.
Treat a CAPTCHA, login, timeout, outage, private record, or other portal failure as unknown.
Retain the certificate as document-only evidence and use the issuer contact route without claiming verification.
Keep the record unresolved until an exact issuer result or documented issuer confirmation is available.
Certificate structure
Keep the full packet. All 17 retained records are multi-page and some contain four pages.
Verify each issuer and panel independently; a pharmacy page and a Freedom Diagnostics page do not share one verification result.
Evidence boundaries
Review receipts
Public search record
The official verification form and the pharmacy’s own correction notice are the primary sources. Aggregated COA collections are not issuer records.
Sources
Reusable integration rule: Classify the issuer accurately, store product/strength, client/lot, and test date, retain the full packet, and route each attached lab panel to its own issuer.
Check the document